07.06.2020 Views

Neuro amelioration of cinnamaldehyde in aluminum induced Alzheimer s disease rat model

Aluminum (Al) is a neurotoxic substance which has played an important role in the etiology, pathogenesis, and development of amyloid-β (Aβ) plaques. This study was carried out to evaluate the neuroprotective effect of aqueous cinnamon extract against aluminum chloride (AlCl3)-induced Alzheimer's disease. Forty adult male albino rats, randomly divided into four equal groups. Control group; ACE200 group administered aqueous cinnamon extract (ACE) orally; AlCl3 group received daily intraperitoneal (i.p.) injection of AlCl3 for 60 days to induce neurotoxicity and AlCl3 + ACE200 group received a combination of AlCl3 and ACE in the same dose and route as previous groups. Aluminum administration significantly enhanced the memory impairment and the Aβ formation in the rat model. The cerebellum exhibited a significant reduced number of Purkinje cells, marked decrease in the density of dendritic arborization and prominent perineuronal spaces in the molecular layer. There was loss of dendritic spines, neurofibrillary degeneration, and appearance of neuritic plaques. Concomitant administration of AlCl3 and ACE displayed an observable protection against these changes with progressive improvement in memory and intellectual performance. In conclusion, ACE may play a protective role against formation of amyloid-β plaques in cerebellum. Keywords: Alzheimer; aluminum chloride; amyloid beta; apoptosis; cinnamon; memory.



Aluminum (Al) is a neurotoxic substance which has played an important role in the etiology, pathogenesis, and development of amyloid-β (Aβ) plaques. This study was carried out to evaluate the neuroprotective effect of aqueous cinnamon extract against aluminum chloride (AlCl3)-induced Alzheimer's disease. Forty adult male albino rats, randomly divided into four equal groups. Control group; ACE200 group administered aqueous cinnamon extract (ACE) orally; AlCl3 group received daily intraperitoneal (i.p.) injection of AlCl3 for 60 days to induce neurotoxicity and AlCl3 + ACE200 group received a combination of AlCl3 and ACE in the same dose and route as previous groups. Aluminum administration significantly enhanced the memory impairment and the Aβ formation in the rat model. The cerebellum exhibited a significant reduced number of Purkinje cells, marked decrease in the density of dendritic arborization and prominent perineuronal spaces in the molecular layer. There was loss of dendritic spines, neurofibrillary degeneration, and appearance of neuritic plaques. Concomitant administration of AlCl3 and ACE displayed an observable protection against these changes with progressive improvement in memory and intellectual performance. In conclusion, ACE may play a protective role against formation of amyloid-β plaques in cerebellum.

Keywords: Alzheimer; aluminum chloride; amyloid beta; apoptosis; cinnamon; memory.

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Journal of Histotechnology

ISSN: 0147-8885 (Print) 2046-0236 (Online) Journal homepage: https://www.tandfonline.com/loi/yhis20

Neuro-amelioration of cinnamaldehyde in

aluminum-induced Alzheimer’s disease rat model

Hesham N. Mustafa

To cite this article: Hesham N. Mustafa (2020) Neuro-amelioration of cinnamaldehyde in

aluminum-induced Alzheimer’s disease rat model, Journal of Histotechnology, 43:1, 11-20, DOI:

10.1080/01478885.2019.1652994

To link to this article: https://doi.org/10.1080/01478885.2019.1652994

Published online: 28 Aug 2019.

Submit your article to this journal

Article views: 117

View related articles

View Crossmark data

Full Terms & Conditions of access and use can be found at

https://www.tandfonline.com/action/journalInformation?journalCode=yhis20


JOURNAL OF HISTOTECHNOLOGY

2020, VOL. 43, NO. 1, 11–20

https://doi.org/10.1080/01478885.2019.1652994

Neuro-amelioration of cinnamaldehyde in aluminum-induced Alzheimer’s

disease rat model

Hesham N. Mustafa

Anatomy Department, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia

ABSTRACT

Aluminum (Al) is a neurotoxic substance which has played an important role in the etiology,

pathogenesis, and development of amyloid-β (Aβ) plaques. This study was carried out to evaluate

the neuroprotective effect of aqueous cinnamon extract against aluminum chloride (AlCl 3 )-

induced Alzheimer’s disease. Forty adult male albino rats, randomly divided into four equal

groups. Control group; ACE200 group administered aqueous cinnamon extract (ACE) orally;

AlCl 3 group received daily intraperitoneal (i.p.) injection of AlCl 3 for 60 days to induce neurotoxicity

and AlCl 3 + ACE200 group received a combination of AlCl 3 and ACE in the same dose and

route as previous groups. Aluminum administration significantly enhanced the memory impairment

and the Aβ formation in the rat model. The cerebellum exhibited a significant reduced

number of Purkinje cells, marked decrease in the density of dendritic arborization and prominent

perineuronal spaces in the molecular layer. There was loss of dendritic spines, neurofibrillary

degeneration, and appearance of neuritic plaques. Concomitant administration of AlCl 3 and ACE

displayed an observable protection against these changes with progressive improvement in

memory and intellectual performance. In conclusion, ACE may play a protective role against

formation of amyloid-β plaques in cerebellum.

KEYWORDS

Alzheimer; aluminum

chloride; cinnamon;

memory; amyloid beta;

apoptosis

Introduction

Aluminum (Al) is a neurotoxin that leads to development

of anxiety disorders, depression, memory deficits,

and symptoms similar to those for Alzheimer′s disease

(AD) [1]. Aluminum accumulates in the body through

medical interventions such as renal dialysis, vaccines,

antiperspirants, and allergy desensitization injections

[2]. Bondy reported that Al can induce programmed

cell death, vacuolar spaces, distortion in the architecture

and loss of Purkinje cell layer of cerebellar cortex

[3].

In addition, amyloid-β (Aβ) oxidative stress has

a critical role in Aβ-mediated neuronal cytotoxicity

by triggering neurodegeneration in AD [4]. Oxidative

damage and excessive reactive oxygen species (ROS)

production are initiated during earlier stages of AD

and induce mild cognitive impairment [5].

Additionally, oxidative damage has been associated

with mitochondrial membrane damage, dysfunction,

and lipid peroxidation elevation that plays

a significant role in the pathogenesis of brain disorders

induced by Al [6].

Astrocytes are vital for the optimal physiological

functions and existence of neurons as these are the

most plentiful glial cell type in the nervous system

[7–9]. Glial fibrillary acidic protein (GFAP) is the

chief intermediate filament protein of mature astrocytes

and is known as the astrocyte-specific marker

responsible for controlling astrocyte movement and

shape; thus, GFAP has the crucial role in modulating

synaptic efficiency [9,10].

Aqueous (aq) cinnamon extract (ACE) has been

associated with a variety of beneficial effects. The

antioxidant properties are attributed to cinnamaldehyde

and polymeric polyphenol molecules known as

proanthocyanidins [11]. These molecules have

inhibited amyloid fibril formation by interacting

with the polyphenols and Aβ [12,13] and through

a high binding affinity of proanthocyanidins to

unstructured proteins rich in proline [14]. The aq.

cinnamon extract effectively inhibited aggregation

of tau related to AD, and this inhibitory activity

was attributed to both a proanthocyanidin trimer

and cinnamaldehyde [13]. Studies showed that the

potentially toxic compounds in cinnamon bark were

found in lipid-soluble fractions, while low levels of

these compounds were in a water-soluble extract

[15] that is considered safer for uptake.

CONTACT Hesham N. Mustafa hesham977@hotmail.com Anatomy Department, Faculty of Medicine, King Abdulaziz University, JEDDAH 21589,

Saudi Arabia

© 2019 National Society for Histotechnology


12 H. N. MUSTAFA

Therefore, the aim of this study was to clarify the

protective effect of aq. cinnamon extract on aluminum

neurotoxicity model for AD on the behavior changes

and cerebellar pathology in rats.

Material and methods

Ethical approval

This study was conducted after approval by the

Medical Research Ethics Committee of the Faculty of

Medicine, King Abdulaziz University [Reference No

220–19].

Animals

Forty male adult Wistar rats (6 wk of age) weighing

200 ± 20 g were obtained from the university Animal

House and were distributed randomly into four

groups of animals (n = 10). The rats were individually

housed in stainless steel cages at controlled temperature

(22 ± 2°C) and humidity (55 ± 10%) for a 12/12

h cycle of light/dark with access to food and drinking

water ad libitum. The experimental procedures were

carried out in accordance with the international

guidelines for the care and use of animals in the

laboratory.

Chemicals

Aluminum chloride (AlCl 3 ) (Cat No 8010810500;

MilliporeSigma, St Louis, MO, USA).

Preparation of cinnamon extract

Cinnamomum cassia obtained from local spice market

at Jeddah, Saudi Arabia and ground into a powder then

50 g of cinnamon powder was dissolved in 500 ml of

distilled water (dH 2 O) and boiled for 3 h. This mixture

was concentrated to make an oily extract using a rotary

evaporator (EYELA, Rotary Vacuum Evaporator,

N-1000 series, Tokyo Rikakikai Co., Ltd., Chuo-ku,

Tokyo, Japan) and lyophilized to obtain 12.48 g of

cinnamon powder [16].

Experimental design

Control group received dH 2 O through oral gavage.

ACE200 group were administered 200 mg/kg b. w./

day aq cinnamon extract (ACE) orally for 60 days

[11,14] and the selected dose was based on toxicity

studies carried out in our laboratory. AlCl 3 group was

given 100 mg/kg b.w. intraperitoneally (i.p.) for 60 days

according to a previously reported dose that caused

neurotoxicity [17–19]. AlCl 3 exposure was chosen

according to European Food Safety Authority that

recommended the aluminum mean occupational exposure

of adult humans (0.2–1.5 mg/kg-week) [20]. The

combination AlCl 3 and ACE200 group received the

same doses and routes as the separate AlCl 3 group

and ACE200 group.

Rewarded T-maze test

The neurocognitive function was evaluated by the

rewarded T-maze test for rats as described by Deacon

and Rawlins [21]. Before the experiment, the rat is

trained where it is allowed to explore the whole maze

and rewarded with food at completion of the test. The

rats were denied food for 24 h but allowed to have

water. At the start of the test, the rat is placed in the

start location, and the time in second which the rat

spends to reach the end of each arm was recorded

using an auto stopwatch. The test was done within 4

days of training rats to perform. All groups were subjected

to the rewarded T-maze test which was done:

Trial 1 was at zero time before starting, Trial 2 was 24

h after AlCl 3 and Trial 3 was 24 h after the last dose of

the drugs for all groups [22].

Measurement of aluminum level in cerebella

The whole cerebella of randomly chosen rats (n =4)

from each group were carefully separated, removed and

washed by ice-cold (4ºC) normal saline, weighed and

put into a solution containing 0.05 ml nitric acid

(1004551000, MilliporeSigma, St. Louis, MO, USA)

and 0.2 ml hydrogen peroxide (H 2 O 2 ) (386790,

MilliporeSigma), then whole tissue mixture was incubated

at 120°C for 2 h. The aluminum level in cerebella

measured by µg/g was determined by an atomic

absorption spectrophotometer (PinAAcle500, Perkin

Elmer, Waltham, MA, USA) [23,24].

Cerebellum histology

At the end of the experiment, the remaining animals

were euthanized. The cerebellum surgically removed,

weighed, and fixed in 10% neutral buffered formalin

(NBF) for 24 h. Tissues were processed through an

ascending ethyl alcohol gradient (50%, 70%, 90%, and

95%) 30 min each for, 100% ethyl alcohol for 1

h (two changes), cleared in xylene for 1 h (two

changes), infiltrated with paraffin at 60°C for 2

h and embedded in paraffin. Sections 5 µm thick

were cut using a rotatory microtome (Shandon,


JOURNAL OF HISTOTECHNOLOGY 13

Finesse 325, ThermoFisher Scientific, Luton,

England), and mounted on slides precoated with an

egg albumin–glycerol adhesive. Sections were deparaffinized

in xylene (three changes, 15 min each) and

rehydrated through a descending alcohol gradient

(100%, 90%, 70%) 5–10 min each change to diH 2 0.

Sections were stained 10 min in Harris hematoxylin

(HHS16, MilliporeSigma,), washed in tap H 2 O to

‘blue’ the nuclei, counterstained in Alcoholic Eosin

Y (515, 3,801,615; Leica Biosystems Inc., Buffalo

Grove, IL, USA) for 5 min., dehydrated through an

ascending alcohol gradient, cleared in xylene, and

coverslipped using Canada balsam (C1795,

MilliporeSigma) [10].

Congo red stain for the amyloid β

Sections were deparaffinized and rehydrated as previously

described, and stained in Congo red solution

(1% Congo red in dH 2 O) (C-6277, MilliporeSigma) for

30–60 min, then rinse in distilled water. Differentiated

(5–10 dips) in alkaline alcohol solution (1% sodium

hydroxide + 50% alcohol). Then counterstained in hematoxylin

(23–750016, MilliporeSigma) for 30 sec, blued in

ammonia water for 30 sec, rinsed in tap H 2 Ofor5min,

dehydrated through 95% and 100% alcohols, cleared in

xylene and cover glass mounted with resinous mounting

medium [6,7].

Bielschowsky silver stain for amyloid plaques

Bielshowsky silver stain can be used for diagnosis of AD.

Sections were deparaffinized and rehydrated as described

above. Slides are placed in pre-warmed (40ºC) silver

nitrate (AgNO 3 ) solution (0.1 mol Titrisol, 109990,

MilliporeSigma) for 15 min until sections become

a brown color then washed in diH 2 O 3 times. The ammoniacal

silver stain solution (AgNO 3 /NH 4 OH) was prepared

as follows: conc. ammonium hydroxide (NH 4 OH,

221228, MilliporeSigma), is added to the AgNO 3 solution

drop by drop until the precipitate formed just turns clear.

Slides were returned to the AgNO 3 /NH 4 OH solution for

30 min in 40ºC oven followed by direct immersion into

the developer solution for about 1 min. The developer is

made with 20 ml of 40% formaldehyde (818708,

MilliporeSigma), 100 ml dH 2 O, 20 µl conc. nitric acid

(1004551000, MilliporeSigma), and 0.5 g citric acid

(sodium citrate, S4641, MilliporeSigma). Slides were

dipped for 1 min in 1% NH 4 OH to stop the silver reaction,

washed in dH 2 O 3 times, and placed in 5% aq.

sodium thiosulfate for 5 min. Sections were dehydrated,

cleared, and coverslipped [7].

Immunohistochemical (IHC) study

Immunostaining for glial fibrillary acidic protein

(GFAP) in the astrocytes was done on deparaffinized

sections after antigen retrieval and removal of endogenous

peroxidase as done by Saleh et al. [7]. The

Histostain-Plus IHC Kit, HRP, broad spectrum

(859,043, Invitrogen, Carlsbad CA, USA) with diaminobenzidene

(DAB) chromogen was used according to

kit instructions. The primary antibody was Anti-GFAP

(Anti-glial fibrillary acidic protein, mouse monoclonal,

IgG, clone GA5, MAB3402, RRID: AB_94844

MilliporeSigma) diluted 1:1000 and incubated overnight

at 4°C. The negative control was sectioned from

dH 2 O control group with PBS replacing the anti-GFAP

antibody. GFAP-positive (GFAP+) astrocytes will display

brown cellular membranes and cytoplasm with

blue nuclei [7,9].

Quantitative morphometric study

Sections from all groups were examined using an

Olympus BX53 microscope fitted with a DP73 camera

(Olympus, Tokyo, Japan). Ten slides of nonoverlapping

fields from each group with one slide

from each animal were analyzed with Image-Pro

Plus v6 (Media Cybernetics Inc., Bethesda, MD,

USA). For each rat in all groups, the number of

Purkinje cells were counted from 10 lobules in each

cerebellar section at 200x magnification. The average

value of Purkinje cells was calculated for these 10

lobules per section. The total length of the cerebellar

folia in the 10 lobules was estimated in µm then

converted into millimeter (mm). Purkinje cells =

mean value of cell number ÷ length (mm) of the

cerebellar folia according to McGoey et. al [25].

Also, the area percent for GFAP expressed in astrocytes

and in their processes in cerebellar cortices

were measured.

Statistical analysis

Quantitative data were expressed as the mean and

standard deviations of different parameters (transit

time spent in the T-maze test, linear density of

Purkinje cells/mm length of the folia and area percent

of GFAP+ astrocytes) between the treated groups. Data

were analyzed using a one-way analysis of variance

(ANOVA) followed by a least significant difference

(LSD) post hoc test. All statistical analyses were implemented

using the Statistical Package for the Social

Sciences (SPSS), version 23. The values were considered

significant when p < 0.05.


14 H. N. MUSTAFA

Results

T-maze test

The results demonstrated a significant increase in time

(seconds) taken by rats in the AlCl 3 group to reach the

food in the T-maze indicating a deteriorated neurocognitive

function. Whereas the AlCl 3 + ACE200 group showed

asignificant decrease in time taken by rats to reach food in

the T-Maze indicating improved cognitive abilities as compared

to the AlCl 3 group. Additionally, the ACE200 group

showed a significant decrease in time to achieve the task, as

compared to the control group (Table 1).

Data are presented as mean ± SE (n =10).Meanwith

different superscripts (a, b, c, d, e) are significant at p ≤

0.05. Trial 1 was at zero time before starting, Trial 2 was

24 h after AlCl 3 and Trial 3 was 24 h after the last dose for

all groups. T-maze transit time is in sec.

Aluminum level in cerebella

AlCl 3 levels in cerebella were detected by atomic absorption

spectrophotometry. Results showed that AlCl 3 treatment

had a significantly elevated Al level as compared to

control group. Otherwise, ACE200 administration inhibited

the increase of Al level (Figure 1, Table 2).

Table 1. Therapeutic effects of ACE on the transit time spent in

the T-maze by experimental groups.

Groups Trial 1 (sec.) Trial 2 (sec.) Trial 3 (sec.)

Control 13.12 ± 2.12 a 16.57 c ± 4.70 14.88 a ± 1.14

ACE200 12.73 a ± 0.94 14.45 c ± 0.98 15.00 a ± 2.77

AlCl 3 18.92 d ± 3.91 25.39 e ± 3.12 23.36 e ± 4.66

AlCl 3 + ACE200 15.27 a ± 2.09 20.00 b ± 1.57 18.43 c ± 3.82

Table 2. Therapeutic effects of ACE on AL level in different

groups.

Group

Al level (µg/g) wet tissue.

Control

3.14 ± 0.12

(n =4)

ACE200

3.92 ± 0.81

(n =4)

AlCl 3

(n =4)

AlCl 3 + ACE200

(n =4)

Each value represents the mean ± S.D.; P 1 : compared

to control, P 2: compared to ACE200, P 3: compared to

AlCl 3 .

Cerebellar histology

10.34 ± 0.49

P 1 < 0.001

P 2 < 0.001

6.27 ± 1.90

P 1 < 0.01

P 2 < 0.05

P 3 < 0.001

Each value represents the mean ± S.D.; P 1 : compared to Control, P 2:

compared to ACE200, P 3: compared to AlCl 3 . n= number of rats

Cell alteration and disintegration were compared to control.

Neurons were morphologically damaged and showed

shrunken pyknotic hyperchromatic nuclei in AlCl 3 group.

In AlCl 3 + ACE200 group, the extent of neuronal damage

was declined significantly. Also, Cellular morphology was

improved and no sign of degeneration was observed as

compared to controls (Figure 2).

In AlCl 3 group, Congo red staining results demonstrated

that noticeable amyloid β plaques were distributed

in the molecular layer and rare amyloid plaques were seen

in the granular layer. Amyloid plaques exhibited a light

red mass without distinct borders. In AlCl 3 +ACE200

group, the positively stained areas of amyloid plaques

were markedly reduced with a normal, restored appearance

and numbers of Purkinje cell layer (Figure 3).

Immunohistochemical results

AlCl 3 group showed many GFAP + hypertrophic astrocytes

with extensive branching of processes extending

into the molecular cell layer. In the AlCl 3 + ACE200

group, there was a decrease in the number of GFAP +

astrocytes (Figure 4), and these findings are supported

statistically (Figure 4).

Morphometric and statistical results

Figure 1. Therapeutic effects of ACE on aluminum level in

different groups.

As compared with the control group, the Purkinje cells in

the AlCl 3 group were significantly reduced in number

although Purkinje cells in the AlCl3 + ACE200 group

were significantly increased in number. There was also

asignificant increase in the mean number of astrocytes in

AlCl 3 group as compared to astrocyte numbers in the

other three groups. There was a significant decrease in the


JOURNAL OF HISTOTECHNOLOGY 15

Figure 2. Photomicrographs of cerebellar cortex sections from experimental groups. (a) Control group molecular layer (M) has small

stellate cells (SC), and basket cells (BC). The Purkinje cell layer (P) has large pyriform somata with prominent nucleoli, and the

granular layer (G) shows tightly packed small rounded cells with deeply stained nuclei. (b) ACE200 group exhibited normal

morphology. (c) AlCl 3 group exhibited a normal molecular layer (M). Few Purkinje cells (arrow) are found in the Purkinje cell layer (P)

and have irregular size, shape, darkly stained nuclei and cytoplasm (arrow). Prominent perineuronal spaces (stars) are seen around

basket (BC) and stellate cells (SC) in the molecular layer (M). The granular layer (G) appears unaffected but obvious amyloid plaques

(Aβ) were detected. (d) AlCl 3 + ACE200 group molecular (M), the granular (G), and the Purkinje cell layers (P) have restored

appearance and numbers. The Purkinje cells (arrows) are slightly reduced in number. (H&E, Scale bar = 20 µm).

Figure 3. Photomicrographs of cerebellar cortex sections from experimental groups. (a) Control with the three cerebellar layers,

Purkinje (P), molecular (M) and granular (G). (b) ACE200 group exhibits normal morphology. (c) AlCl 3 group shows a reduced

number of Purkinje layer cells (arrow) with irregular darkly stained cytoplasm (arrow), and amyloid plaques (Aβ). (d) AlCl 3 + ACE200

group shows the Purkinje layer (P) has a restored appearance and number of cells. (Congo red, Scale bar = 20 µm).


16 H. N. MUSTAFA

Figure 4. Photomicrographs of cerebellar cortex sections from experimental groups. (a) Control group shows GFAP + astrocytes with

long and thin processes (star) and granular layer protoplasmic astrocytes with thick processes (arrowhead). (b) ACE200 group

exhibited GFAP + astrocytes with small oligodendrocytes (arrowhead) and spindle-shaped microglia (star). (c) AlCl 3 group exhibited

an increase in the number of GFAP + astrocytes with relatively longer processes (arrowheads). (d) AlCl 3 + ACE200 group showed

relatively fewer numbers of astrocytes with thin processes (arrowheads) (GFAP, scale bar = 20 µm).

a

Linear density of Purkinje

cells/mm length of the folia

25

20

15

10

5

P 1 < 0.001

P 2 < 0.001

P 1 < 0.001

P 2 < 0.001

P 3 < 0.001

b

Area percent of GFAP +

astrocytes

6

5

4

3

2

1

P 1 < 0.001

P 2 < 0.001

P 1 < 0.001

P 2 < 0.001

P 3 < 0.001

0

Control ACE200 AlCl 3

AlCl 3 +

ACE200

0

Control ACE200 AlCl 3

AlCl 3 +

ACE200

Figure 5. (a) The linear density of Purkinje cells/mm length of the folia. (b) Area percent of GFAP + astrocytes.

mean number of astrocytes in AlCl 3 +ACE200group

(Figures 5 a,b, Table 3).

Data are represented as mean ± SD. P 1 : as compared to

control, P 2: as compared to ACE200, P 3 : as compared to

AlCl 3 .

Data are represented as mean ± SD. P 1 : as compared to

control, P 2: as compared to ACE200, P 3 : as compared to

AlCl 3 .

Bielschowsky results

In AlCl 3 group, modified Bielschowsky results demonstrated

an obvious heavily stained brown amyloid plaques

with irregular border in the molecular layer. In

AlCl 3 + ACE200 group, the amyloid plaques were

markedly reduced with improvements in the morphology

of the cerebellum (Figure 6).


JOURNAL OF HISTOTECHNOLOGY 17

Table 3. The linear density of Purkinje cells/mm length of the

folia and area percent of GFAP + astrocytes.

Groups Purkinje cells GFAP + (n = 200)

Control 21.74 ± 0.98 1.37 ± 0.43

ACE200 21.57 ± 0.96 1.54 ± 0.23

AlCl 3 3.35 ± 0.71 4.63 ± 0.35

P 1 < 0.001 P 1 < 0.001

P 2 < 0.001 P 2 < 0.001

AlCl 3 + ACE200 15.73 ± 1.02 2.28 ± 0.83

P 1 < 0.001 P 1 < 0.001

P 2 < 0.001 P 2 < 0.001

P 3 < 0.001 P 3 < 0.001

Data are represented as mean ± SD. P 1 : compared to control, P 2: compared

to ACE200, P 3: compared to AlCl 3 . n = 200 is the number of cells counted.

Discussion

The findings of the current study are in accordance with

other studies for cerebellum in Alzheimer’s disease, with

deterioration of the cerebellar volume due to damaged

Purkinje neurons and smalled cell bodies. Dendrites disintegration,

decline of dendritic fields density, dendritic

spines were lost and a marked increase of focal lipid

storage within the dendritic arborization [4,12,26].

The duration and dose of AlCl 3 administration was

selected to induce AD symptoms based on previous findings

[27,28]. Even though the dose of AlCl 3 may be higher

than routine human exposure (0.4–1.7 mg/kg b.w./day),

humans are sometimes exposed to higher levels of AlCl 3

during occupational toxicity and dialysis encephalopathy

[29–31]. Moreover, humans are exposed to aluminum

through various ways such as cooking utensils and drinking

water [32].

Aluminum exposure caused a significant decrease in

body and brain weights in rats in a study by Mohamed

and Abd El-Moneium [33] and this could be attributed to

the interference by the aluminum on the hormonal status

and/or protein synthesis [34]. Furthermore, the decrease

in brain weight might be due to increased lipid peroxidation

as a consequence of oxidative stress [31].

The AlCl 3 group showed a significant decrease in the

behavior scores as compared with the control and AlCl 3 +

ACE200 group in T-maze test. This study coincided with

Wu, Li et al. that proved the deposition of Aβ plaques

in AD brains impairs learning and memory [35].

Cinnamaldehyde is effective in preventing the tau

knots by prohibiting oxidative stress, as cinnamaldehyde

binds to two residues of the amino cysteine on the

tau protein. The cysteine residues are vulnerable to

these modifications, which have contributed to the

development of Alzheimer’s disease. This could explain

why ACE reduced the cerebellar Al level in the current

study, may be the other mechanism related to neuroprotective

effects by ACE [36].

In the current study, Al exposure resulted in

asignificant reduction in the number of Purkinje cells.

This agreed with studies that reported disorganization of

the Purkinje cell layer with a loss of Purkinje cells with Al

exposure [1]. A darkly stained cytoplasm and pyknotic

nuclei were observed in the Purkinje cells. Pyknosis was

described as irreversible condensation of nuclear chromatin

in cells undergoing programmed cell death or

apoptosis [37]. These results are in agreement with the

Figure 6. Photomicrographs of cerebellum sections from experimental groups. (a) Control exhibited the three cerebellar layers.

Purkinje (P), molecular (M) and granular (G). (b) ACE200 group displayed the same normal morphological findings as indicated in

Figures 1 and 2. (c) ALCl 3 group revealed shrunken pyknotic Purkinje cells and with obvious large, dark irregular amyloid plaques

(Aβ). (d) AlCl 3 + ACE200 group showed notable improvement of any signs of degeneration (Bielschowsky, scale bar = 20 µm).


18 H. N. MUSTAFA

histological findings in the cerebellar cortex after Al treatment

investigated by El–Shafei and colleagues [38].

This study showed that the molecular layer was

characterized by the presence of diffuse plaques and

absence of typical neuritic plaques which was in accordance

with work by Mavroudis et. al [4]. The main

difference between these two types of plaques was the

amyloid-β protein nature that is present. Diffuse plaques

in the cerebellum are known to be positive for the

end specific monoclonal antibodies Aβ 1–42 but not

Aβ 1–40 [12,26]. This agreed with Du et al. who

noticed that metabolites from cerebellar neurons

encouraged the expression of Aβ degrading enzymes

and advance the clearance of Aβ [4].

Astrocytes play active roles in neuronal regulation

and modulation [39]. It has also been suggested that

the loss of astrocyte functions may precede neurodegeneration

and aluminum could be a contributing factor

for this loss [40]. Astrocytes are the principal target

of the action of aluminum [39] that can cause astrocyte

death through apoptosis [41].

The current findings showed a significant increase in

GFAP immunoreactivity of astrocytes in AlCl 3 group,

which is in accordance with previous findings and may

be related to a generic response of the central nervous

system to neural injury [42]. Injury to the parenchyma

of the brain induced many plump reactive astrocytes.

These researchers added that as a response to injury,

they also observed the production of a dense network

of processes and increased synthesis of GFAP. The role

of astrocytes in central nervous system (CNS) disorders

remains of interest. The present study showed

a significant increase in the number of GFAP + astrocytes

in AlCl 3 group and this finding indicated that

AlCl 3 altered the production and degradation of GFAP,

the marker of reactive astrocytosis. Thus, GFAP

expression has been a relevant marker for studying

neurodegenerative changes. In contrast, other researchers

have found decreased GFAP expression in the cerebellar

cortex [43,44].

Gliosis might be mediated indirectly through the

free radical formation and herbal antioxidants may

help in preventing this reactive gliosis possibly by

reducing the damaging effects of ROS. Based on this

postulation, the use of ACE in the present study significantly

reduced GFAP expression in cerebellar cortex

thus protecting the memory and learned ability as

reported by other authors [9,45].

Conclusion

Aqueous Cinnamon Extract (ACE) may be considered

an efficacious therapeutic strategy to alleviate amyloidβ

plaques. It is recommended to avoid using of aluminum

cooking utensils, water tubing and to control

occupational exposure.

Disclosure statement

No potential conflict of interest was reported by the author.

ORCID

Hesham N. Mustafa

2187

References

http://orcid.org/0000-0003-1188-

[1] Bhalla P, Dhawan DK. Protective role of lithium in

ameliorating the aluminium-induced oxidative stress

and histological changes in rat brain. Cell Mol

Neurobiol. 2009;29(4):513–521.

[2] Krewski D, Yokel RA, Nieboer E, et al. Human health

risk assessment for aluminium, aluminium oxide, and

aluminium hydroxide. J Toxicol Environ Health B Crit

Rev. 2007;10(Suppl 1):1–269.

[3] Bondy SC. Low levels of aluminum can lead to behavioral

and morphological changes associated with

Alzheimer’s disease and age-related neurodegeneration.

Neurotoxicol. 2016;52:222–229.

[4] Mavroudis IA, Manani MG, Petrides F, et al. Dendritic

and spinal pathology of the Purkinje cells from the

human cerebellar vermis in Alzheimer’s disease.

Psychiatr Danub. 2013;25(3):221–226.

[5] Abu-Taweel GM, Ajarem JS, Ahmad M. Neurobehavioral

toxic effects of perinatal oral exposure to aluminum on the

developmental motor reflexes, learning, memory and

brain neurotransmitters of mice offspring. Pharmacol

Biochem Behav. 2012;101(1):49–56.

[6] Nobakht M, Hoseini SM, Mortazavi P, et al.

Neuropathological changes in brain cortex and hippocampus

in a rat model of Alzheimer’s disease. Iran

Biomed J. 2011;15(1–2):51–58.

[7] Suvarna KS, Layton C, Bancroft JD. Bancroft’s theory

and practice of histological techniques. UK: Elsevier

Health Sciences; 2019.

[8] Saleh HA, Abd El-Aziz GS, Mustafa HN, et al.

Thymoquinone ameliorates oxidative damage and histopathological

changes of developing brain

neurotoxicity. J Histotechnol. 2019;1–12.

[9] Frydman-Marom A, Levin A, Farfara D, et al. Orally

administrated cinnamon extract reduces β-amyloid

oligomerization and corrects cognitive impairment in

Alzheimer’s disease animal models. PloS One. 2011;6

(1):e16564.

[10] Mustafa HN, Hussein AM. Does allicin combined with

vitamin B-complex have superior potentials than

alpha-tocopherol alone in ameliorating lead

acetate-induced Purkinje cell alterations in rats? An

immunohistochemical and ultrastructural study. Folia

Morphol (Warsz). 2016;75(1):76–86.


JOURNAL OF HISTOTECHNOLOGY 19

[11] Azab K, Mostafa AH, Ali EM, et al. Cinnamon

extract ameliorates ionizing radiation-induced cellular

injury in rats. Ecotoxicol Environ Saf. 2011;74

(8):2324–2329.

[12] Mavroudis IA, Fotiou DF, Adipepe LF, et al.

Morphological changes of the human purkinje cells and

deposition of neuritic plaques and neurofibrillary tangles

on the cerebellar cortex of Alzheimer’s disease. Am

J Alzheimers Dis Other Demen. 2010;25(7):585–591.

[13] Peterson DW, George RC, Scaramozzino F, et al.

Cinnamon extract inhibits tau aggregation associated

with Alzheimer’s disease in vitro. J Alzheimers Dis.

2009;17(3):585–597.

[14] Morgan AM, El-Ballal SS, El-Bialy BE, et al. Studies

on the potential protective effect of cinnamon

against bisphenol A- and octylphenol-induced oxidative

stress in male albino rats. Toxicol Rep.

2014;1:92–101.

[15] Otto AD. Cinnamon as a supplemental treatment for

impaired glucose tolerance and type 2 diabetes. Curr

Diab Rep. 2010;10(3):170–172.

[16] Parvazi S, Sadeghi S, Azadi M, et al. The effect of

aqueous extract of cinnamon on the metabolome of

plasmodium falciparum using (1)HNMR spectroscopy.

J Trop Med. 2016;2016:3174841.

[17] Justin Thenmozhi A, Raja TR, Janakiraman U, et al.

Neuroprotective effect of hesperidin on aluminium

chloride induced Alzheimer’s disease in Wistar rats.

Neurochem Res. 2015;40(4):767–776.

[18] Cao Z, Wang F, Xiu C, et al. Hypericum perforatum

extract attenuates behavioral, biochemical, and neurochemical

abnormalities in Aluminum chlorideinduced

Alzheimer’s disease rats. Biomed

Pharmacother. 2017;91:931–937.

[19] Cao Z, Yang X, Zhang H, et al. Aluminum chloride

induces neuroinflammation, loss of neuronal dendritic

spine and cognition impairment in developing rat.

Chemosphere. 2016;151:289–295.

[20] European Food Safety Authority E. Dietary exposure

to aluminium-containing food additives. EFSA

Supporting Publ. 2013;10(4):411E.

[21] Deacon RM, Rawlins JN. T-maze alternation in the

rodent. Nat Protoc. 2006;1(1):7–12.

[22] Farr SA, Ripley JL, Sultana R, et al. Antisense oligonucleotide

against GSK-3beta in brain of SAMP8 mice

improves learning and memory and decreases oxidative

stress: Involvement of transcription factor Nrf2

and implications for Alzheimer disease. Free Radic

Biol Med. 2014;67:387–395.

[23] Wei Y, Liu D, Zheng Y, et al. Protective effects of

kinetin against aluminum chloride and D-galactose

induced cognitive impairment and oxidative damage

in mouse. Brain Res Bull. 2017;134:262–272.

[24] Justin Thenmozhi A, Dhivyabharathi M, William

Raja TR, et al. Tannoid principles of Emblica officinalis

renovate cognitive deficits and attenuate amyloid

pathologies against aluminum chloride induced rat

model of Alzheimer’s disease. Nutr Neurosci. 2016;19

(6):269–278.

[25] McGoey TN, Reynolds JN, Brien JF. Chronic prenatal

ethanol exposure-induced decrease of guinea pig

hippocampal CA1 pyramidal cell and cerebellar

Purkinje cell density. Can J Physiol Pharmacol.

2003;81(5):476–484.

[26] Mavroudis IA, Fotiou DF, Manani MG, et al.

Dendritic pathology and spinal loss in the visual cortex

in Alzheimer’s disease: a Golgi study in pathology.

Int J Neurosci. 2011;121(7):347–354.

[27] Nampoothiri M, Kumar N, Venkata Ramalingayya G,

et al. Effect of insulin on spatial memory in aluminum

chloride-induced dementia in rats. Neuroreport.

2017;28(9):540–544.

[28] Saba K, Rajnala N, Veeraiah P, et al. Energetics of

excitatory and inhibitory neurotransmission in aluminum

chloride model of Alzheimer’s disease: reversal of

behavioral and metabolic deficits by Rasa Sindoor.

Front Mol Neurosci. 2017;10:323.

[29] Niu Q, Yang Y, Zhang Q, et al. The relationship

between Bcl-2 gene expression and learning & memory

impairment in chronic aluminum-exposed rats.

Neurotox Res. 2007;12(3):163–169.

[30] Bhattacharjee S, Zhao Y, Hill JM, et al. Aluminum and

its potential contribution to Alzheimer’s disease (AD).

Front Aging Neurosci. 2014;6:62.

[31] Mathiyazahan DB, Justin Thenmozhi A,

Manivasagam T. Protective effect of black tea

extract against aluminium chloride-induced

Alzheimer’s disease in rats: A behavioural, biochemical

and molecular approach. J Funct Foods.

2015;16:423–435.

[32] Ali HA, Afifi M, Abdelazim AM, et al. Quercetin and

omega 3 ameliorate oxidative stress induced by aluminium

chloride in the brain. J Mol Neurosci. 2014;53

(4):654–660.

[33] Mohamed NE, Abd El-Moneim AE. Ginkgo biloba

extract alleviates oxidative stress and some neurotransmitters

changes induced by aluminum chloride in rats.

Nutrition. 2017;35:93–99.

[34] Wenting L, Ping L, Haitao J, et al. Therapeutic effect of

taurine against aluminum-induced impairment on

learning, memory and brain neurotransmitters in

rats. Neurol Sci. 2014;35(10):1579–1584.

[35] Wu QY, Li J, Feng ZT, et al. Bone marrow stromal

cells of transgenic mice can improve the cognitive

ability of an Alzheimer’s disease rat model. Neurosci

Lett. 2007;417(3):281–285.

[36] George RC, Lew J, Graves DJ. Interaction of cinnamaldehyde

and epicatechin with tau: implications

of beneficial effects in modulating Alzheimer’s disease

pathogenesis. J Alzheimers Dis. 2013;36

(1):21–40.

[37] Venkataraman P, Selvakumar K, Krishnamoorthy G,

et al. Effect of melatonin on PCB (Aroclor 1254)

induced neuronal damage and changes in Cu/Zn

superoxide dismutase and glutathione peroxidase-4

mRNA expression in cerebral cortex, cerebellum and

hippocampus of adult rats. Neurosci Res. 2010;66

(2):189–197.

[38] El–Shafei M-DE-DM, Kamel AMF, Mostafa MEA.

Effect of aluminum on the histological structure of

ratsʼ cerebellar cortex and possible protection by

melatonin. Egypt J Histol. 2011;34(2):239–250.


20 H. N. MUSTAFA

[39] Araque A, Navarrete M. Glial cells in neuronal network

function. Philos Trans R Soc Lond B Biol Sci.

2010;365(1551):2375–2381.

[40] Guo GW, Liang YX. Aluminum-induced apoptosis in

cultured astrocytes and its effect on calcium

homeostasis. Brain Res. 2001;888(2):221–226.

[41] Suarez-Fernandez MB, Soldado AB, Sanz-Medel A,

et al. Aluminum-induced degeneration of astrocytes

occurs via apoptosis and results in neuronal death.

Brain Res. 1999;835(2):125–136.

[42] Nedzvetsky VS, Tuzcu M, Yasar A, et al. Effects of

vitamin E against aluminum neurotoxicity in rats.

Biochemistry (Mosc). 2006;71(3):239–244.

[43] Exley C. Aluminium and Alzheimer’s disease: the

science that describes the link. UK: Elsevier Science;

2001.

[44] Silva AF, Aguiar MS, Carvalho OS, et al. Hippocampal

neuronal loss, decreased GFAP immunoreactivity and

cognitive impairment following experimental intoxication

of rats with aluminum citrate. Brain Res.

2013;1491(Supplement C):23–33.

[45] Modi KK, Roy A, Brahmachari S, et al. Cinnamon and

its metabolite sodium benzoate attenuate the activation

of p21rac and protect memory and learning in an

animal model of Alzheimer’s disease. PloS One.

2015;10(6):e0130398.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!